---
title: "Layn released its 2024 annual performance, with a net profit attributable to the parent company of 163 million yuan, a year-on-year increase of 97.56%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/233455522.md"
description: "Layn released its 2024 annual report, with operating revenue of 1.772 billion yuan, a year-on-year increase of 18.60%; net profit attributable to the parent company was 163 million yuan, a year-on-year increase of 97.56%. The net profit excluding non-recurring gains and losses was 151 million yuan, a year-on-year increase of 634.19%. Earnings per share were 0.22 yuan, and it plans to distribute a cash dividend of 1 yuan for every 10 shares. Revenue from the natural sweetener business was 951.9773 million yuan, and revenue from the tea extraction business was 182.2629 million yuan, both maintaining steady growth"
datetime: "2025-03-27T12:20:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/233455522.md)
  - [en](https://longbridge.com/en/news/233455522.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/233455522.md)
---

# Layn released its 2024 annual performance, with a net profit attributable to the parent company of 163 million yuan, a year-on-year increase of 97.56%

According to the Zhitong Finance APP, Layn (002166.SZ) released its 2024 annual report. During the reporting period, the company achieved operating revenue of 1.772 billion yuan, a year-on-year increase of 18.60%. The net profit attributable to shareholders of the listed company was 163 million yuan, a year-on-year increase of 97.56%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 151 million yuan, a year-on-year increase of 634.19%. The basic earnings per share were 0.22 yuan. The company plans to distribute a cash dividend of 1 yuan (including tax) for every 10 shares to all shareholders.

During the reporting period, the company's natural sweetener business achieved operating revenue of 951.9773 million yuan, a year-on-year increase of 5.46%. This was mainly due to the decline in the market price of monk fruit raw materials in 2023, which led to a decrease in raw material costs and prompted corresponding adjustments in product prices. However, the sales volume of natural sweetener products still achieved significant growth, and the market demand for natural sweeteners continued to show a positive trend, reflecting customers' high recognition of the company's product technology advantages and brand value. Currently, the company is closely aligning with industry development trends, deepening strategic layout, and accelerating the promotion of new product research and development and channel promotion. In the future, it will further enhance capacity synergy efficiency and promote healthy growth in performance and market share. In terms of tea extract business, during the reporting period, Huagao Bio's tea extract products maintained a leading advantage in the U.S. market and continuously expanded the market through product innovation. Based on changes in market demand, the company focused on advancing the research and development of new tea extract products such as theanine and catechins, achieving mass production of pure natural theanine products. In 2024, the company's tea extract business achieved operating revenue of 182.629 million yuan, maintaining a steady growth rate

### Related Stocks

- [002166.CN](https://longbridge.com/en/quote/002166.CN.md)

## Related News & Research

- [DiagnaMed Completes Acquisition of Colchester East Natural Hydrogen Project in Nova Scotia | DGNMF Stock News](https://longbridge.com/en/news/286557566.md)
- [Kauri NZ Stake Diluted After Comvita Capital Raise](https://longbridge.com/en/news/286840418.md)
- [UAE-India economic, investment ties witnessing rapid growth: UIBC-UC](https://longbridge.com/en/news/286880497.md)
- [05:15 ETSino Biological Launches XPressMAX™ Cell-Free Protein Synthesis Kit, Accelerating AI-Powered High-Throughput Antibody Drug Discovery](https://longbridge.com/en/news/286885164.md)
- [US Senator Durbin urges RFK. Jr to resist easing vape rules](https://longbridge.com/en/news/287079463.md)